Presentation is loading. Please wait.

Presentation is loading. Please wait.

What‘s the science behind Fresubin® 2 kcal/ fibre DRINK?

Similar presentations


Presentation on theme: "What‘s the science behind Fresubin® 2 kcal/ fibre DRINK?"— Presentation transcript:

1 What‘s the science behind Fresubin® 2 kcal/ fibre DRINK?
Wendy Martin Medical Scientific Affairs KIC BU Enteral Nutrition KIC BU EN, MSA, WMa, December

2 Contents Malnutrition & oral nutritional supplements (ONS)
How to make patients take ONS? General indications for Fresubin® 2 kcal/ fibre DRINK Special indications for Fresubin® 2 kcal/ fibre DRINK: Renal failure with dialysis treatment Liver diseases Chronic obstructive pulmonary disease Cardiovascular diseases KIC BU EN, MSA, WMa, December

3 Consequences of malnutrition
KIC BU EN, MSA, WMa, December

4 Consequences of malnutrition
Physical functioning ⇩ Resistance to infection ⇩, wound healing ⇩, muscle atrophy … KIC BU EN, MSA, WMa, December

5 Consequences of malnutrition
Physical functioning ⇩ Resistance to infection ⇩, wound healing ⇩, muscle atrophy … Risk of complications ⇧ KIC BU EN, MSA, WMa, December

6 Consequences of malnutrition
Physical functioning ⇩ Resistance to infection ⇩, wound healing ⇩, muscle atrophy … Risk of complications ⇧ Time to recovery and hospital stay ⇧ KIC BU EN, MSA, WMa, December

7 Consequences of malnutrition
Physical functioning ⇩ Resistance to infection ⇩, wound healing ⇩, muscle atrophy … Risk of complications ⇧ Time to recovery and hospital stay ⇧ Therapeutic costs ⇧ Mortality ⇧ KIC BU EN, MSA, WMa, December

8 Can we do something about it?
Evidence for oral nutritional supplements KIC BU EN, MSA, WMa, December

9 Evidence for ONS Preservation of appetite
Overall higher intake of nutrients Improved functional outcomes Reduced hospital stay → potential cost benefit Decreased complication rates Decreased mortality KIC BU EN, MSA, WMa, December

10 Evidence for ONS Preservation of appetite
Overall higher intake of nutrients Improved functional outcomes Reduced hospital stay → potential cost benefit Decreased complication rates Decreased mortality Evidence-based ESPEN guidelines 2006 KIC BU EN, MSA, WMa, December

11 Evidence doesn‘t help when the patient just won‘t take the sip!
KIC BU EN, MSA, WMa, December

12 How to make patients take ONS?
KIC BU EN, MSA, WMa, December

13 Most important feature of a successful product:
Compliance Most important feature of a successful product: KIC BU EN, MSA, WMa, December

14 Most important feature of a successful product:
Compliance Most important feature of a successful product: GREAT TASTE!!! KIC BU EN, MSA, WMa, December

15 Most important feature of a successful product:
Compliance Most important feature of a successful product: GREAT TASTE!!! and a low volume KIC BU EN, MSA, WMa, December

16 Compliance GREAT TASTE!!!
Most important feature of a successful product: GREAT TASTE!!! and a low volume Patients do take about 400 ml ONS a day and not much more. (e.g. Roberts M et al., British Journal of Nutrition 2003) KIC BU EN, MSA, WMa, December

17 Compliance GREAT TASTE!!!
Most important feature of a successful product: GREAT TASTE!!! and a low volume Patients do take about 400 ml ONS a day and not much more. (e.g. Roberts M et al., British Journal of Nutrition 2003)  So we packed these 400 ml with nutrition KIC BU EN, MSA, WMa, December

18 400 ml Fresubin® 2 kcal/ fibre DRINK
KIC BU EN, MSA, WMa, December

19 400 ml Fresubin® 2 kcal/ fibre DRINK
40 g protein KIC BU EN, MSA, WMa, December

20 400 ml Fresubin® 2 kcal/ fibre DRINK
40 g protein All vitamins All minerals and trace elements KIC BU EN, MSA, WMa, December

21 400 ml Fresubin® 2 kcal/ fibre DRINK
40 g protein With or without prebiotic fibre All vitamins All minerals and trace elements KIC BU EN, MSA, WMa, December

22 400 ml Fresubin® 2 kcal/ fibre DRINK
40 g protein With or without prebiotic fibre All vitamins All minerals and trace elements Energy% of protein, fat, carbs 20 : 35 : 45 KIC BU EN, MSA, WMa, December

23 High nutrient density – low volume
KIC BU EN, MSA, WMa, December

24 High nutrient density – low volume
Low volume  better compliance for prescribed supplementation in all indications for standard ONS KIC BU EN, MSA, WMa, December

25 High nutrient density – low volume
Low volume  better compliance for prescribed supplementation in all indications for standard ONS ? But what about tolerance of Fresubin® 2 kcal/ fibre DRINK? KIC BU EN, MSA, WMa, December

26 Tolerance test with Fresubin® 2 kcal DRINK
KIC BU EN, MSA, WMa, December

27 Tolerance test with Fresubin® 2 kcal DRINK
Randomised, controlled, double-blind, multicentre study In 84 healthy elderly 400 ml/ day or KIC BU EN, MSA, WMa, December

28 Tolerance test results in healthy elderly
2 kcal/ ml vs 1.5 kcal/ ml KIC BU EN, MSA, WMa, December

29 Tolerance test results in healthy elderly
2 kcal/ ml vs 1.5 kcal/ ml equally well tolerated KIC BU EN, MSA, WMa, December

30 General indications for the high energy, high protein
Fresubin® 2 kcal/ fibre DRINK KIC BU EN, MSA, WMa, December

31 Scientific view on ONS 1 kcal Geriatric patients Cancer HIV
Peri-operative patients Cardiac & circulatory failure COPD Liver diseases Dialysis 1 kcal 1.5 kcal 2 kcal KIC BU EN, MSA, WMa, December

32 Indications for high energy ONS
All general indications which go for standard ONS go for Fresubin® 2 kcal/ fibre DRINK PLUS conditions with fluid restriction KIC BU EN, MSA, WMa, December

33 Indications for high energy ONS
All general indications which go for standard ONS go for Fresubin® 2 kcal/ fibre DRINK PLUS conditions with fluid restriction KIC BU EN, MSA, WMa, December

34 Indications for high energy ONS
All general indications which go for standard ONS go for Fresubin® 2 kcal/ fibre DRINK PLUS conditions with fluid restriction …provided there is no need for protein restriction. KIC BU EN, MSA, WMa, December

35 Additionally valuable: High protein
20 energy% of protein KIC BU EN, MSA, WMa, December

36 Additionally valuable: High protein
Proteins are needed for e.g. cell building, enzymes, antibodies, and hormones. Protein needs are increased in conditions like: Renal failure with dialysis treatment Liver diseases Chronic obstructive pulmonary disease Cardiovascular diseases Pressure ulcers, stress, ageing, …. 20 energy% of protein KIC BU EN, MSA, WMa, December

37 Additionally valuable: High protein
Proteins are needed for e.g. cell building, enzymes, antibodies, and hormones. Protein needs are increased in conditions like: Renal failure with dialysis treatment Liver diseases Chronic obstructive pulmonary disease Cardiovascular diseases Pressure ulcers, stress, ageing, …. 20 energy% of protein KIC BU EN, MSA, WMa, December

38 Additionally valuable: High protein
Proteins are needed for e.g. cell building, enzymes, antibodies, and hormones. Protein needs are increased in conditions like: Renal failure with dialysis treatment Liver diseases Chronic obstructive pulmonary disease Cardiovascular diseases . 20 energy% of protein KIC BU EN, MSA, WMa, December

39 Special indications for the high energy, high protein
Fresubin® 2 kcal/ fibre DRINK: KIC BU EN, MSA, WMa, December

40 Special indications for the high energy, high protein
Fresubin® 2 kcal/ fibre DRINK: Renal failure with dialysis treatment Liver diseases Chronic obstructive pulmonary disease Cardiovascular diseases KIC BU EN, MSA, WMa, December

41 Dialysis induces catabolism
Hypermetabolism Body protein breakdown Nutrient loss with dialysis NEEDS (e.g.Cano N et al., Clin Nutr 2006) KIC BU EN, MSA, WMa, December

42 Dialysis induces catabolism
Hypermetabolism Body protein breakdown Nutrient loss with dialysis NEEDS INTAKE Anorexia Fluid restriction Gastrointestinal impairments (e.g.Cano N et al., Clin Nutr 2006) KIC BU EN, MSA, WMa, December

43 Dialysis induces catabolism
Hypermetabolism Body protein breakdown Nutrient loss with dialysis NEEDS INTAKE Anorexia Fluid restriction Gastrointestinal impairments Malnutrition in up to 70% of dialysis patients! (e.g.Cano N et al., Clin Nutr 2006) KIC BU EN, MSA, WMa, December

44 Satisfying increased needs
KIC BU EN, MSA, WMa, December

45 Satisfying increased needs
Hypermetabolism Body protein breakdown Nutrient loss with dialysis NEEDS KIC BU EN, MSA, WMa, December

46 Satisfying increased needs
Hypermetabolism Body protein breakdown Nutrient loss with dialysis NEEDS INTAKE High energy and high protein in a small volume KIC BU EN, MSA, WMa, December

47 Satisfying increased needs
Hypermetabolism Body protein breakdown Nutrient loss with dialysis NEEDS INTAKE High energy and high protein in a small volume  ESPEN KIC BU EN, MSA, WMa, December

48 Fresubin® 2 kcal DRINK in dialysis patients
ESPEN guidelines 2006 (expert opinion): In dialysis patients, standard ONS can be used. KIC BU EN, MSA, WMa, December

49 Fresubin® 2 kcal DRINK in dialysis patients
ESPEN guidelines 2006 (expert opinion): In dialysis patients, standard ONS can be used. We had a first look at Fresubin® 2 kcal DRINK in dialysis patients: KIC BU EN, MSA, WMa, December

50 Fresubin® 2 kcal DRINK in dialysis patients
ESPEN guidelines 2006 (expert opinion): In dialysis patients, standard ONS can be used. We had a first look at Fresubin® 2 kcal DRINK in dialysis patients: Randomised, controlled study In 20 dialysis patients or Renilon 7.5 KIC BU EN, MSA, WMa, December

51 Study results indicate:
Renilon 7.5 Standard versus disease specific KIC BU EN, MSA, WMa, December

52 Study results indicate:
Renilon 7.5 Standard versus disease specific no relevant influences on serum electrolytes KIC BU EN, MSA, WMa, December

53 Study results indicate:
Renilon 7.5 Standard versus disease specific no relevant influences on serum electrolytes equally well tolerated KIC BU EN, MSA, WMa, December

54 Special indications for the high energy, high protein
Fresubin® 2 kcal/ fibre DRINK: Renal failure with dialysis treatment Liver diseases Chronic obstructive pulmonary disease Cardiovascular diseases KIC BU EN, MSA, WMa, December

55 Liver: Control unit of metabolism
KIC BU EN, MSA, WMa, December

56 Liver: Control unit of metabolism
Fat metabolism Protein Carbohydrate Energy KIC BU EN, MSA, WMa, December

57 Liver: Control unit of metabolism
Fat metabolism Protein Vitamins and trace elements Carbohydrate Energy KIC BU EN, MSA, WMa, December

58 Liver: Control unit of metabolism
Fat metabolism Protein Vitamins and trace elements Carbohydrate Energy Hormone balance KIC BU EN, MSA, WMa, December

59 Liver: Control unit of metabolism
Fat metabolism Protein Vitamins and trace elements Carbohydrate Energy Hormone balance Digestion KIC BU EN, MSA, WMa, December

60 Liver: Control unit of metabolism
Fat metabolism Protein Vitamins and trace elements Carbohydrate Energy Hormone balance Digestion Detoxication, acid base balance, …. KIC BU EN, MSA, WMa, December

61 Liver: Control unit of metabolism
The development of malnutrition in liver diseases is complex Fat metabolism Protein Vitamins and trace elements Carbohydrate Energy Hormone balance Digestion Detoxication, acid base balance, …. KIC BU EN, MSA, WMa, December

62 Liver diseases and malnutrition
Up to 60% of liver patients are malnourished KIC BU EN, MSA, WMa, December

63 Liver diseases and malnutrition
Up to 60% of liver patients are malnourished with increased risk of complications like: Ascites Hepatic encephalopathy Severe infections Mortality (e.g. Cabré E et al., Gastroenterology 1990) KIC BU EN, MSA, WMa, December

64 Liver diseases and malnutrition
Up to 60% of liver patients are malnourished with increased risk of complications like: Ascites Hepatic encephalopathy Severe infections Mortality Tackle malnutrition with high energy, high protein oral nutritional supplements! (e.g. Cabré E et al., Gastroenterology 1990) KIC BU EN, MSA, WMa, December

65 Liver diseases and malnutrition
Up to 60% of liver patients are malnourished with increased risk of complications like: Ascites Hepatic encephalopathy Severe infections Mortality Tackle malnutrition with high energy, high protein oral nutritional supplements!  ESPEN (e.g. Cabré E et al., Gastroenterology 1990) KIC BU EN, MSA, WMa, December

66 Special indications for the high energy, high protein
Fresubin® 2 kcal/ fibre DRINK: Renal failure with dialysis treatment Liver diseases Chronic obstructive pulmonary disease Cardiovascular diseases KIC BU EN, MSA, WMa, December

67 COPD Chronic Obstructive Pulmonary Disease
KIC BU EN, MSA, WMa, December

68 COPD Chronic Obstructive Pulmonary Disease
Altered enzyme/ cytokine activity KIC BU EN, MSA, WMa, December

69 COPD Chronic Obstructive Pulmonary Disease
Altered enzyme/ cytokine activity Altered substrate metabolism KIC BU EN, MSA, WMa, December

70 COPD Chronic Obstructive Pulmonary Disease
Altered enzyme/ cytokine activity Altered substrate metabolism Hyper- metabolism KIC BU EN, MSA, WMa, December

71 COPD Chronic Obstructive Pulmonary Disease
Altered enzyme/ cytokine activity Altered substrate metabolism Hyper- metabolism Malnutrition KIC BU EN, MSA, WMa, December

72 COPD Chronic Obstructive Pulmonary Disease
Altered enzyme/ cytokine activity Altered substrate metabolism Hyper- metabolism Malnutrition KIC BU EN, MSA, WMa, December

73 COPD Chronic Obstructive Pulmonary Disease
Systemic inflammation Altered enzyme/ cytokine activity Altered substrate metabolism Hyper- metabolism Malnutrition KIC BU EN, MSA, WMa, December

74 COPD Chronic Obstructive Pulmonary Disease
Systemic inflammation Altered enzyme/ cytokine activity Altered substrate metabolism Hyper- metabolism Malnutrition Anorexia KIC BU EN, MSA, WMa, December

75 COPD Chronic Obstructive Pulmonary Disease
Systemic inflammation Altered enzyme/ cytokine activity Altered substrate metabolism Hyper- metabolism Malnutrition Anorexia Muscle waisting KIC BU EN, MSA, WMa, December

76 COPD Chronic Obstructive Pulmonary Disease
Systemic inflammation Altered enzyme/ cytokine activity Altered substrate metabolism Hyper- metabolism Malnutrition Anorexia Muscle waisting Skeletal muscle weakness KIC BU EN, MSA, WMa, December

77 COPD Chronic Obstructive Pulmonary Disease
Malnutrition Systemic inflammation Anorexia Altered enzyme/ cytokine activity Altered substrate metabolism Hyper- metabolism Muscle waisting Skeletal muscle weakness Reduced breathing capacity KIC BU EN, MSA, WMa, December

78 COPD Chronic Obstructive Pulmonary Disease
Up to 40% of COPD patients are malnourished. KIC BU EN, MSA, WMa, December

79 COPD Chronic Obstructive Pulmonary Disease
Up to 40% of COPD patients are malnourished. Anorexia Hyper- metabolism Muscle waisting Malnutrition KIC BU EN, MSA, WMa, December

80 COPD Chronic Obstructive Pulmonary Disease
Up to 40% of COPD patients are malnourished. Anorexia Hyper- metabolism Muscle waisting Malnutrition KIC BU EN, MSA, WMa, December

81 COPD Chronic Obstructive Pulmonary Disease
Up to 40% of COPD patients are malnourished. High energy, high protein ONS KIC BU EN, MSA, WMa, December

82 COPD Chronic Obstructive Pulmonary Disease
Up to 40% of COPD patients are malnourished. High energy, high protein ONS  ESPEN KIC BU EN, MSA, WMa, December

83 COPD Chronic Obstructive Pulmonary Disease
Up to 40% of COPD patients are malnourished. High energy, high protein ONS have been shown to improve nutritional status, physical functioning, and survival  ESPEN (e.g. Schols AM et al., Am J Respir Crit Care Med Steiner MC et al., Thorax 2003) KIC BU EN, MSA, WMa, December

84 Special indications for the high energy, high protein
Fresubin® 2 kcal/ fibre DRINK: Renal failure with dialysis treatment Liver diseases Chronic obstructive pulmonary disease Cardiovascular diseases KIC BU EN, MSA, WMa, December

85 Cardiovascular diseases
KIC BU EN, MSA, WMa, December

86 Cardiovascular diseases
Neurohormones KIC BU EN, MSA, WMa, December

87 Cardiovascular diseases
Neurohormones Renin-angiotensin system KIC BU EN, MSA, WMa, December

88 Cardiovascular diseases
Neurohormones Renin-angiotensin system Water retention KIC BU EN, MSA, WMa, December

89 Cardiovascular diseases
Neurohormones Renin-angiotensin system Water retention Cytokines KIC BU EN, MSA, WMa, December

90 Cardiovascular diseases
Neurohormones Renin-angiotensin system Water retention Cytokines Acute phase response KIC BU EN, MSA, WMa, December

91 Cardiovascular diseases
Neurohormones Renin-angiotensin system Water retention Catabolism Acute phase response Cytokines KIC BU EN, MSA, WMa, December

92 Cardiovascular diseases
About 15% of cardiac patients are malnourished. (e.g. Anker SD et al., Clin Nutr Von Haehling S et al., Cardiovas Res 2007) KIC BU EN, MSA, WMa, December

93 Cardiovascular diseases
About 15% of cardiac patients are malnourished. Water retention + catabolism (e.g. Anker SD et al., Clin Nutr Von Haehling S et al., Cardiovas Res 2007) KIC BU EN, MSA, WMa, December

94 Cardiovascular diseases
About 15% of cardiac patients are malnourished. Water retention + catabolism = need for high energy and high protein supplementation within a low volume (e.g. Anker SD et al., Clin Nutr Von Haehling S et al., Cardiovas Res 2007) KIC BU EN, MSA, WMa, December

95 Cardiovascular diseases
About 15% of cardiac patients are malnourished. Water retention + catabolism = need for high energy and high protein supplementation within a low volume  ESPEN (e.g. Anker SD et al., Clin Nutr Von Haehling S et al., Cardiovas Res 2007) KIC BU EN, MSA, WMa, December

96 Take home messages ….great taste and good tolerance
make Fresubin® 2 kcal/ fibre DRINK indicated for most patients with or at risk of malnutrition …low fluid load and high protein supply provide the rationale for the use of Fresubin® 2 kcal/ fibre DRINK in - Renal failure with dialysis treatment Liver diseases Chronic obstructive pulmonary disease Cardiovascular diseases KIC BU EN, MSA, WMa, December

97 Thanks for your attention!
KIC BU EN, MSA, WMa, December


Download ppt "What‘s the science behind Fresubin® 2 kcal/ fibre DRINK?"

Similar presentations


Ads by Google